Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Prepaid Assets: 2010-2024

Historic Prepaid Assets for Iovance Biotherapeutics (IOVA) over the last 10 years, with Dec 2024 value amounting to $12.4 million.

  • Iovance Biotherapeutics' Prepaid Assets was N/A to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year change of. This contributed to the annual value of $12.4 million for FY2024, which is 29.10% down from last year.
  • Iovance Biotherapeutics' Prepaid Assets amounted to $12.4 million in FY2024, which was down 29.10% from $17.5 million recorded in FY2023.
  • In the past 5 years, Iovance Biotherapeutics' Prepaid Assets registered a high of $17.5 million during FY2023, and its lowest value of $12.4 million during FY2024.
  • In the last 2 years, Iovance Biotherapeutics' Prepaid Assets had a median value of $14.9 million in 2023 and averaged $14.9 million.
  • Data for Iovance Biotherapeutics' Prepaid Assets shows a maximum YoY dropped of 29.10% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Iovance Biotherapeutics' Prepaid Assets stood at $17.5 million in 2023, then decreased by 29.10% to $12.4 million in 2024.